Ark Genomic Revolution Ucits ETF AccumUSD (IT:ARKG) Price & Chart
IT:ARKG ETF Chart & Stats
- Day’s Range
- EUR 8.03 - EUR 8.34
- 52-Week Range
- EUR 4.09 - EUR 9.72
- Previous Close
- EUR 8.20
- Volume
- 13.65K
- Average Volume (3M)
- 24.76K
- AUM
- 105.23M
- NAV
- 8.09
- Expense Ratio
- 0.79%
- Holdings Count
- 35
- Beta
- 0.50
- Inception Date
- Apr 12, 2024
- Last Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
- Shares Outstanding
- 13,344,864
- Standard Deviation
- N/A
ETF Overview
Ark Genomic Revolution Ucits ETF AccumUSD
The Ark Genomic Revolution UCITS ETF AccumUSD (Ticker: IT:ARKG) is an innovative financial instrument designed to capture the explosive growth and transformative potential within the genomics sector. This exchange-traded fund (ETF) is strategically crafted for investors seeking exposure to advancements in genomic science, a niche that is poised to redefine healthcare, agriculture, and overall quality of life through cutting-edge technologies. As a sector-focused ETF, IT:ARKG meticulously curates a portfolio of companies at the forefront of genomic innovations, including those involved in gene editing, DNA sequencing, bioinformatics, and molecular diagnostics. The ETF's thematic concentration on genomic advancements positions it uniquely within the market, offering investors a targeted approach to capitalize on the anticipated breakthroughs and commercial applications in personalized medicine and biotechnology. With a commitment to identifying and investing in companies that are leading the genomic revolution, Ark Genomic Revolution UCITS ETF AccumUSD provides a dynamic investment vehicle for those who believe in the transformative power of science and technology. By investing in IT:ARKG, stakeholders are not only tapping into a sector with significant growth potential but also contributing to the future of healthcare and scientific discovery.